Malaysia-based private equity firm Xeraya Capital announced on Wednesday its participation in a globally syndicated $50 million Series C investment in Congenica, a UK-headquartered digital health company that claims to provide rapid and accurate analysis of complex genomic data.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
